I disagree.
Recession resilience requires capital sustainability. This company remains dependent on the market appetite for funding it. Management need to seriously begin to moving toward break even and not just targeting it near term (like they have since 2017).
They also massively overpaid for the large acquisition, and these result show it.
The appeal has always been its innovative approach to solving serious problems and this has been recognised by its rapid growth, however that's evidently tempering, while the cost of that growth has steadily been rising.
Management have a lot of work to do here.
- Forums
- ASX - By Stock
- QOR
- Ann: Quarterly Activities Report and Appendix 4C
QOR
qoria limited
Add to My Watchlist
0.00%
!
46.5¢

Ann: Quarterly Activities Report and Appendix 4C, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
46.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $612.7M |
Open | High | Low | Value | Volume |
45.5¢ | 47.5¢ | 45.5¢ | $1.530M | 3.255M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 27299 | 46.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.5¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 27299 | 0.465 |
4 | 55695 | 0.460 |
1 | 60000 | 0.455 |
3 | 162222 | 0.450 |
2 | 62000 | 0.445 |
Price($) | Vol. | No. |
---|---|---|
0.475 | 100000 | 1 |
0.480 | 100000 | 1 |
0.485 | 410000 | 3 |
0.490 | 144500 | 3 |
0.495 | 100000 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
QOR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online